(Q46566643)

23 December 2017

title

Peroxisome proliferator-activated receptor delta as a molecular target to regulate lung cancer cell growth (English)

1 reference

23 December 2017

1 reference

1 reference

Keiko Fukumoto

1

1 reference

23 December 2017

Yoshihisa Yano

2

1 reference

23 December 2017

Nantiga Virgona

3

1 reference

23 December 2017

Hiromi Hagiwara

4

1 reference

23 December 2017

Hiromi Sato

5

1 reference

23 December 2017

Hironobu Senba

6

1 reference

23 December 2017

Kazuyuki Suzuki

7

1 reference

23 December 2017

Ryuji Asano

8

1 reference

23 December 2017

Kazuhiko Yamada

9

1 reference

23 December 2017

Tomohiro Yano

10

1 reference

23 December 2017

language of work or name

English

0 references

publication date

1 July 2005

1 reference

23 December 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

FEBS Letters

1 reference

23 December 2017

volume

579

1 reference

23 December 2017

issue

17

1 reference

23 December 2017

page(s)

3829-3836

1 reference

23 December 2017

cites work

Cancer statistics, 1998.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.004

Effect of a selective cyclooxygenase-2 inhibitor, nimesulide, on the growth of lung tumors and their expression of cyclooxygenase-2 and peroxisome proliferator- activated receptor-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.004

Induction of cytosolic phospholipase A2 by oncogenic Ras in human non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.004

Celecoxib reduces pulmonary inflammation but not lung tumorigenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.004

Pharmacodynamic profile of prostacyclin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.004

Prostacyclin and thromboxane synthases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.004

Prostacyclin in human non-small cell lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.004

Pulmonary prostacyclin synthase overexpression chemoprevents tobacco smoke lung carcinogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.004

A novel pathway of prostacyclin signaling-hanging out with nuclear receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.004

Prostaglandin E2 reinforces the activation of Ras signal pathway in lung adenocarcinoma cells via EP3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.004

Negative growth control of renal cell carcinoma cell by connexin 32: possible involvement of Her-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.004

DNA binding properties of peroxisome proliferator-activated receptor subtypes on various natural peroxisome proliferator response elements. Importance of the 5'-flanking region

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.004

Prostacyclin-dependent apoptosis mediated by PPAR delta

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.004

Pharmacological analysis of wild-type alpha, gamma and delta subtypes of the human peroxisome proliferator-activated receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.004

Nonsteroidal anti-inflammatory drugs stimulate spermidine/spermine acetyltransferase and deplete polyamine content in colon cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.004

The inhibitory effect of vitamin E on pulmonary polyamine biosynthesis, cell proliferation and carcinogenesis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.004

The modulation effect of vitamin E on prostaglandin E2 level and ornithine decarboxylase activity at the promotion phase of lung tumorigenesis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.004

Prostaglandin E2 activates Src signaling in lung adenocarcinoma cell via EP3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.004

Role of BAX in the apoptotic response to anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.004

Cyclooxygenase-independent Induction of Apoptosis by Sulindac Sulfone Is Mediated by Polyamines in Colon Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.004

Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.004

10.1016/J.FEBSLET.2005.06.004

21 January 2018

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017